Fungicide Launched in Brazil Controls Major Soybean Diseases

Brazilian company Nortox has unveiled to MKTPlace its latest innovation for soybean disease control: Scudeiro, an exclusive and unprecedented fusion designed to combat rust and target spot. This fungicide, composed of Protioconazole and Tebuconazole, has been meticulously crafted to stand out as the primary choice for the initial soybean application.

Commercial Director João Marcos Ferrari emphasizes Nortox’s commitment to providing comprehensive solutions for farmers, extending beyond the mere sale of active ingredients. According to him, all possible combinations among fungicide groups were tested, leading to the conclusion of the mixture of two triazoles.

In turn, Célio Hiroyuki Fudo, Product Development Manager, stated that the synergy between Protioconazole and Tebuconazole ensured “efficacy in controlling Asian rust,” demonstrating “excellent performance in combating other soybean diseases.”

Thiago Polles, Market Development Leader, highlights that Scudeiro is a broad-spectrum systemic fungicide, registered for various crops such as cotton, corn, wheat, barley, and sorghum, eliminating the need for adjuvant oil.

The distinctive formulation of Scudeiro, developed in 27 research institutions in Brazil and Cooperative Trials, has proven effective in controlling diseases such as target spot and Asian rust, ensuring productivity and being selective for soybean cultivation.

Maicom Tumiate, Registration and Development Manager, emphasizes the prioritization of the product by the Ministry of Agriculture due to its exclusive and innovative composition, combined with the technical product synthesis and formulation in Brazil.

Lucas Morais, Marketing Coordinator – Communication, underscores that the launch of Scudeiro marks the continuation of the company’s new communication positioning in the market. Celebrating 70 years in April 2024, Nortox adopts a new marketing strategy for Scudeiro and upcoming innovations, moving away from the tradition of naming products after the predominant active ingredient.